229 related articles for article (PubMed ID: 15946752)
1. beta-catenin signaling and regulation of cyclin D1 promoter in NRK-49F cells transformed by down-regulation of the tumor suppressor lysyl oxidase.
Giampuzzi M; Oleggini R; Albanese C; Pestell R; Di Donato A
Biochim Biophys Acta; 2005 Sep; 1745(3):370-81. PubMed ID: 15946752
[TBL] [Abstract][Full Text] [Related]
2. Altered adhesion features and signal transduction in NRK-49F cells transformed by down-regulation of lysyl oxidase.
Giampuzzi M; Oleggini R; Di Donato A
Biochim Biophys Acta; 2003 Apr; 1647(1-2):239-44. PubMed ID: 12686140
[TBL] [Abstract][Full Text] [Related]
3. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
Zhang J; Gill AJ; Issacs JD; Atmore B; Johns A; Delbridge LW; Lai R; McMullen TP
Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
[TBL] [Abstract][Full Text] [Related]
4. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways.
D'Amico M; Hulit J; Amanatullah DF; Zafonte BT; Albanese C; Bouzahzah B; Fu M; Augenlicht LH; Donehower LA; Takemaru K; Moon RT; Davis R; Lisanti MP; Shtutman M; Zhurinsky J; Ben-Ze'ev A; Troussard AA; Dedhar S; Pestell RG
J Biol Chem; 2000 Oct; 275(42):32649-57. PubMed ID: 10915780
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis.
Gotoh J; Obata M; Yoshie M; Kasai S; Ogawa K
Carcinogenesis; 2003 Mar; 24(3):435-42. PubMed ID: 12663502
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of lysyl oxidase-induced tumorigenic transformation in NRK-49F cells characterized by constitutive activation of ras proto-oncogene.
Giampuzzi M; Botti G; Cilli M; Gusmano R; Borel A; Sommer P; Di Donato A
J Biol Chem; 2001 Aug; 276(31):29226-32. PubMed ID: 11323426
[TBL] [Abstract][Full Text] [Related]
7. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway.
Xu G; Li Y; Yoshimoto K; Wu Q; Chen G; Iwata T; Mizusawa N; Wan C; Nie X
Toxicol Lett; 2014 Jan; 224(3):362-70. PubMed ID: 24231000
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IGF-1 signaling by genistein: modulation of E-cadherin expression and downregulation of β-catenin signaling in hormone refractory PC-3 prostate cancer cells.
Lee J; Ju J; Park S; Hong SJ; Yoon S
Nutr Cancer; 2012; 64(1):153-62. PubMed ID: 22098108
[TBL] [Abstract][Full Text] [Related]
9. A growth-promoting signaling component cyclin D1 in neural stem cells has antiastrogliogenic function to execute self-renewal.
Bizen N; Inoue T; Shimizu T; Tabu K; Kagawa T; Taga T
Stem Cells; 2014 Jun; 32(6):1602-15. PubMed ID: 24302516
[TBL] [Abstract][Full Text] [Related]
10. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
Ong CS; Zhou J; Ong CN; Shen HM
Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
[TBL] [Abstract][Full Text] [Related]
11. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.
Shin HS; Lee HJ; Nishida M; Lee MS; Tamura R; Yamashita S; Matsuzawa Y; Lee IK; Koh GY
Circ Res; 2003 Aug; 93(4):302-10. PubMed ID: 12869389
[TBL] [Abstract][Full Text] [Related]
12. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway.
Ji XK; Xie YK; Zhong JQ; Xu QG; Zeng QQ; Wang Y; Zhang QY; Shan YF
Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
Tetsu O; McCormick F
Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
15. GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy.
Takahashi-Yanaga F; Sasaguri T
Cell Signal; 2008 Apr; 20(4):581-9. PubMed ID: 18023328
[TBL] [Abstract][Full Text] [Related]
16. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.
Shtutman M; Zhurinsky J; Simcha I; Albanese C; D'Amico M; Pestell R; Ben-Ze'ev A
Proc Natl Acad Sci U S A; 1999 May; 96(10):5522-7. PubMed ID: 10318916
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II increases fibronectin and collagen I through the β-catenin-dependent signaling in mouse collecting duct cells.
Cuevas CA; Gonzalez AA; Inestrosa NC; Vio CP; Prieto MC
Am J Physiol Renal Physiol; 2015 Feb; 308(4):F358-65. PubMed ID: 25411386
[TBL] [Abstract][Full Text] [Related]
18. DIF-1 inhibits tumor growth in vivo reducing phosphorylation of GSK-3β and expressions of cyclin D1 and TCF7L2 in cancer model mice.
Takahashi-Yanaga F; Yoshihara T; Jingushi K; Igawa K; Tomooka K; Watanabe Y; Morimoto S; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Sasaguri T
Biochem Pharmacol; 2014 Jun; 89(3):340-8. PubMed ID: 24670930
[TBL] [Abstract][Full Text] [Related]
19. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression.
Quasnichka H; Slater SC; Beeching CA; Boehm M; Sala-Newby GB; George SJ
Circ Res; 2006 Dec; 99(12):1329-37. PubMed ID: 17122440
[TBL] [Abstract][Full Text] [Related]
20. Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells.
Shimizu T; Kagawa T; Inoue T; Nonaka A; Takada S; Aburatani H; Taga T
Mol Cell Biol; 2008 Dec; 28(24):7427-41. PubMed ID: 18852283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
